01312.HK
Kontafarma China Holdings Ltd
HKSE · Basic Materials · Construction Materials · HK
HKD 0.03
−3.45%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.7B | 914.7M | 897.5M | 809.1M | 894.1M |
| Cost of Revenue | 805.7M | 401.1M | 381.4M | 337.8M | 387.8M |
| Gross Profit | 927.7M | 513.6M | 516.2M | 471.3M | 506.2M |
| Operating Expenses | |||||
| R&D Expense | 41.8M | 8.4M | 34.6M | 20.8M | 29.1M |
| SG&A Expense | 1.0B | 550.2M | 524.0M | 542.5M | 558.7M |
| General & Admin Expense | 146.7M | 100.2M | 86.3M | 113.0M | 115.3M |
| Selling & Marketing Expense | 691.6M | 452.1M | 437.8M | 429.5M | 443.4M |
| Other Expenses | (2.7M) | — | — | 375.0K | 2.8M |
| Total Operating Expenses | 1.1B | 558.5M | 558.7M | 563.6M | 590.6M |
| Cost and Expenses | 2.1B | 1.2B | 940.0M | 901.4M | 1.0B |
| Operating Income (EBIT) | (341.0M) | (242.8M) | (42.5M) | (164.3M) | (137.3M) |
| Non-Operating | |||||
| Interest Income | 4.7M | 2.0M | 5.8M | 3.5M | 5.2M |
| Interest Expense | 21.6M | 10.8M | 13.4M | 15.3M | 23.3M |
| Net Interest Income | (16.8M) | (8.8M) | (7.6M) | (11.7M) | (18.1M) |
| Other Non-Op Income/Expense | (293.8M) | (211.9M) | (55.5M) | 120.4M | 19.6M |
| Non-Operating Income (excl Interest) | 49.9M | 211.5M | 49.9M | — | (42.8M) |
| EBT (Pre-Tax Income) | (634.7M) | (454.7M) | (98.0M) | (43.9M) | (117.7M) |
| Income Tax Expense | 61.9M | 27.8M | 1.0M | 17.2M | (8.0M) |
| Bottom Line | |||||
| Net Income | (575.6M) | (427.8M) | (75.5M) | (28.8M) | (41.5M) |
| Earnings from Cont. Ops | (661.0M) | (482.6M) | (99.0M) | (61.1M) | (109.7M) |
| Earnings from Discont. Ops | — | — | — | — | 43.3M |
| Bottom Line Net Income | (575.6M) | (427.8M) | (75.5M) | (28.8M) | (41.5M) |
| Per Share | |||||
| Basic EPS | (HK$0.10) | (HK$0.08) | (HK$0.01) | (HK$0.01) | (HK$0.01) |
| Diluted EPS | (HK$0.10) | (HK$0.08) | (HK$0.01) | (HK$0.01) | (HK$0.01) |
| Revenue Per Share | HK$0.31 | HK$0.16 | HK$0.16 | HK$0.15 | HK$0.16 |
| Shares | |||||
| Basic Shares Outstanding | 5.6B | 5.6B | 5.6B | 5.6B | 5.6B |
| Diluted Shares Outstanding | 5.6B | 5.6B | 5.6B | 5.6B | 5.6B |
| Profitability Metrics | |||||
| EBITDA | (212.5M) | (151.8M) | 6.7M | 78.5M | 36.3M |
| D&A | 178.4M | 91.1M | 99.1M | 107.2M | 130.7M |
| EBIT | (390.9M) | (242.8M) | (92.4M) | (164.3M) | (94.5M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026